semaj83/ctmatch_classification huggingface dataset:
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Aphthous Stomatitis Patients willing and able to provide written informed consent for the study Patients with a history of at least three episodes of minor recurrent aphthous stomatitis (RAS) within the past one year  Patients with a history of other forms of RAS (major, herpetiform) Patients who will be using any other vitamins/supplements during the study or those who have used any vitamins/supplements on a regular basis during the 90 days immediately preceding enrollment onto the study (regular use is defined as continuous daily use for at least a two week period) Patients who are under the age of 18 Women who are pregnant or nursing or those who plan to become pregnant Patients with a history of gout, kidney stones or iron overload disease Patients who currently smoke tobacco products Patients who are former smokers who have quit smoking within the past 30 days Patients with sulfite allergy Patients with a history of any systemic condition associated with oral ulceration. These Behcet's syndrome, Sweet's syndrome, Celiac disease, Crohn's disease, ulcerative colitis, HIV infection/AIDS, cyclic neutropenia and PFAPA syndrome (periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis) Patients on medications commonly associated with causing oral ulceration. These nicorandil, methotrexate and chemotherapeutic agents used for cancer
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Influenza Influenza, Human A male or female aged 18-60 years old at the time of vaccination, who previously participated in 108656 clinical trial Subjects who the investigator believes that they can and will comply with the requirements of the protocol Written informed consent obtained from the subject Free of obvious health problems as established by medical history and clinical examination before entering into the study If the subject is female, she must be of non-childbearing potential or, if of childbearing potential, she must be abstinent or have used adequate contraceptive precautions for 30 days prior to vaccination, have a negative pregnancy test and must agree to continue such precautions for two months after completion of the vaccination series  Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine within 30 days preceding the administration of the study vaccine, or planned use during the study period Planned administration of an influenza vaccine other than the study vaccines during the entire study period Previous vaccination against influenza since January 2007 Acute or chronic clinically significant pulmonary, cardiovascular, hepatic or renal functional abnormality, as determined by physical examination or laboratory screening tests Chronic administration of immunosuppressants or other immune-modifying drugs within three months prior to the first vaccine dose Any confirmed or suspected immunosuppressive or immunodeficient condition, based on medical history and physical examination Administration of immunoglobulins and/or any blood products within three months preceding the dose of study vaccine or planned administration during the study period History of hypersensitivity to a previous dose of influenza vaccine History of confirmed influenza infection within the last 12 months Pregnancy
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 13.0-999.0,  Tonsillitis Pharyngitis Patients selected among the cases referred to tonsillectomy for recurrent pharyngitis episodes to a tertiary care university ENT clinic (Oulu, Finland) At least three pharyngitis episodes difficult enough for the patients to seek for medical attention during the past 12 months  Patients with other serious diseases (day surgery not feasible) Patients having long time antibiotic treatment for other disease Patients diagnosed to have peritonsillar abscess Pregnancy Age of 12 or under Patients living outside Oulu or its 8 neighbouring cities (day surgery not feasible) Patients suffering only from halitosis or bacterial plugs of palatine tonsils
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-40.0,  Depression Pregnant woman between 18 and 40 years of age Have depression as their only mental health disorder Have been receiving fluoxetine or citalopram for the treatment of depression for at least one month on the day of study entry for patients in the fluoxetine and citalopram arms, or no pharmacological treatment for patients in the control arm ≤ 26 weeks pregnant by estimated date of confinement Ability to give informed consent Singleton pregnancy Pregnant women no history of depression  Having any comorbid mental disorder other than generalized anxiety disorder as a secondary disorder History of or current epilepsy, endocrine, cardiac, pulmonary, renal or hepatic dysfunction that could negatively influence pregnancy and/or neonatal outcome Abusing alcohol or drugs Use of any self prescribed herbal treatments for depression
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 40.0-60.0,  Heart Disease Healthy Females 60 years of age
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Tonsillitis Age at least 18 years Indication for tonsillectomy (patients undergoing a tonsillectomy as a portion of additional surgical procedures will not be included) Have the ability to understand and the willingness to sign a written informed consent document  History of bleeding disorders History of liver or kidney dysfunction History of allergy to sulfa containing medications History of lactose intolerance History of asthma, urticaria, or allergic-type reactions to aspirin or NSAIDs Women who are currently pregnant, nursing, or trying to conceive History of allergy or intolerance to acetaminophen or hydrocodone History of allergy to any COX-2 inhibitor, including celecoxib or rofecoxib PT, PTT, hemoglobin, or hematocrit values that are outside of institutional limits History of cardiovascular disease
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Healthy Be a cooperative, healthy male or female between the ages of 18-75 inclusive. 2. Have a physical examination which reveals no clinically significant abnormalities at the screening visit. 3. Have fewer than 6 gastric or duodenal erosions visible on nasal endoscopy at Visit 2. 4. If the subject is female and of childbearing potential, she has been using effective contraception since the last date of her menses, will continue to use effective contraception during the study period, is not breast-feeding or lactating at screening and has had a negative urine pregnancy test at screening. Women who have been post-menopausal for less than 2 years will also require a urine pregnancy test at screening. 5. Have provided written informed consent prior for admission to this study. 6. H. pylori negative serologic exam prior to baseline nasal EGD  Active GI disease (e.g. IBD), or a history of GI ulcers or bleeding 2. History of gastric or intestinal surgery 3. Use of ASA, NSAIDs, coxibs, or acetaminophen at any dose within 2 weeks prior to the randomization visit of the study. 4. Positive FOBT at baseline. 5. Use of over-the-counter or prescription: sucralfate, antacids, H2-receptor antagonists, misoprostol, or proton pump inhibitors 4 weeks prior to enrollment and/or during the study 6. A known allergy to the topical anesthetic, lidocaine
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Chronic Lymphocytic Leukemia Untreated stage A CLL patients Healthy volunteers  Patients with other malignancies Patients receiving corticosteroids or other immunosuppressive drugs Patients who have received vaccination against influenza in the past 6 months Patients who have had an allergic reaction to a flu shot in the past, or have an allergy to eggs or who previously developed Guillain-Barré syndrome within 6 weeks of getting a flu shot Patients failing to give informed consent Patients using homeopathic remedies such as echniaea cream
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 0.0-1.0,  Childhood Immunization Completion Childhood Immunization Dropout Immunization Card Center Based Education All children visiting the selected EPI centers for DPT1 immunization  Not residing in the same area for last six months
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Influenza A male or female 18 years of age or greater at the time of the first vaccination Written informed consent obtained from the subject Among 18 to 49 year old subjects, good general health as established by medical history and clinical examination before entering into the study Among subjects > 49 years of age, stable health status within 1 month prior to enrollment Access to a consistent means of telephone contact Comprehension of the study requirements, ability to comprehend and comply with procedures for collection of short and long-term safety data, expressed availability for the required study period, and ability and willingness to attend scheduled visits  Evidence of substance abuse or of neurological or psychiatric diagnoses which, even if clinically stable, are deemed by the investigator to render the potential subjectunable/unlikely to provide accurate safety reports Diagnosed with cancer, or treatment for cancer, within 3 years An oral temperature ≥37.8º C, or acute symptoms greater than "mild" severity on the scheduled date of first vaccination Any confirmed or suspected immunosuppressive or immunodeficient condition including history of human immunodeficiency virus infection Receipt of systemic glucocorticoids within 1 month of study enrollment, or any other cytotoxic or immunosuppressive drug within 6 months of study enrollment Any significant disorder of coagulation or treatment with Coumadin derivatives or heparin Administration of any vaccines within 30 days before study enrollment Previous administration of any H5N1 vaccine Use of any investigational or non-registered product or planned participation in another investigational study within 30 days prior to study enrollment, or during the 364 days following the first test article dose. Use of any investigational or non-registered product with immunosuppressive properties is exclusionary at any time during the trial Receipt of any immunoglobulins and/or any blood products within 3 months of study enrollment or planned administration of any of these products during the study period
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Ocular Melanoma Patients must have uveal melanoma for which enucleation is indicated, usually lesions greater than 8 mm in diameter and greater than 2 mm in thickness Patients should have no evidence of metastatic disease as determined by history, physical examination, and appropriate liver injury enzymes Patients should have received no prior interferon Age >18 years. Because of limited data on the use of pegylated interferon in patients <18 years of age and uncertainties about possible differences in NK response, children are excluded from this study. Since ocular melanoma is rare in children this is not expected to be an issue Life expectancy of greater than 3 months ECOG performance status of 0 (Karnofsky 60% or better; see Appendix II) Patients must have normal organ and marrow function as defined below Hgb >/= 12.5 g/dl or hematocrit >/= 38% Leukocytes >3,000/mcL  Patients who have had agents known to be immunosuppressive (e.g, glucocorticoids) within the 4 weeks prior to planned receipt of study drug Patients receiving any other investigational agents Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements Pregnant women are excluded from this study because interferon alpha has the potential for teratogenic effects. Because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with interferon, breastfeeding should be discontinued if the mother is treated with this agent HIV-positive patients are ineligible because of the known immunosuppression associated with this disease Patients with history of other malignancies are eligible provided that they are clinically free of metastases at the time of the study Patients who have donated blood in the 56 days prior to the 500cc blood draw in this study are not eligible
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Tonsillitis Obstructive Sleep Apnea Patient planned for tonsillectomy for indications of chronic tonsillitis or obstructive sleep apnea Written informed consent form is given from patient or patient's parents (in case of pediatric patient)  Pregnancy History of bleeding disorders Unilateral tonsillectomy Much difference in size of both tonsils (if the difference is more than or equal to 2, it will be defined as much different in size in this study) Patient unable to understand evaluation method Patient unable to be contacted via telephone
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Influenza Male and Female of all age groups Patients exhibiting influenza symptoms (i.e., fever, body aches, headaches, cough, sore throat, and other respiratory symptoms) at the time of examination Patients must either present with a fever (>100ºF; >37.8ºC) at time of examination or have had a fever (>100ºF; >37.8ºC) or declare at time of the examination that they had a fever within the previous 3 days prior to the examination Must be able to collect sample using the nasal swab sample type  Patients with no fever at time of examination or within the 3 days prior to examination and/or are currently undergoing treatment (including anti-virals) will be excluded from the study